MedPath

Sodium Fluoride

These highlights do not include all the information needed to use Sodium Fluoride F 18 Injection safely and effectively. See full prescribing information for Sodium Fluoride F 18 Injection. SODIUM FLUORIDE F 18 INJECTION For Intravenous Use Initial U.S. Approval: 2011

Approved
Approval ID

d867a881-108e-41fa-91ab-dc4df00cbb55

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 7, 2020

Manufacturers
FDA

SOFIE Co. dba SOFIE

DUNS: 957704737

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

SODIUM FLUORIDE F-18

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code49609-002
Application NumberANDA203544
Product Classification
M
Marketing Category
C73584
G
Generic Name
SODIUM FLUORIDE F-18
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateMay 7, 2020
FDA Product Classification

INGREDIENTS (2)

SODIUM FLUORIDE F-18Active
Quantity: 200 mCi in 1 mL
Code: 9L75099X6R
Classification: ACTIM
SODIUM CHLORIDEInactive
Quantity: 9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sodium Fluoride - FDA Drug Approval Details